Physician profile
Shawna Willey
NPI 1619976792
$213,280.68
in general payments reported to CMS, 2019-2025
18 companies · $26K in 2025
The $26K reported for 2025 was more than what 98% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $14K · 2021: $34K · 2022: $46K · 2023: $34K · 2024: $43K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $73K · Travel and Lodging: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $5,172 · Education: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $72,829.00 |
| Travel and Lodging | $14,211.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $5,171.88 |
| Education | $459.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $85,011.76 | 2021-2025 | Biozorb, Localizer, Genius Ai Detection |
| Medtronic, INC. | $47,682.74 | 2021-2025 | Plasmablade(Tm) |
| Pacira Pharmaceuticals Incorporated | $24,876.63 | 2019-2023 | Exparel |
| Endomagnetics Ltd | $18,230.61 | 2019-2025 | Magseed, Magtrace, Sentimag |
| Hologic Sales and Service, LLC | $9,123.86 | 2023-2025 | None, Sentimag, Magseed |
| Genentech USA, INC. | $8,694.19 | 2019-2022 | |
| Medtronic USA, INC. | $8,580.00 | 2020 | |
| Focal Therapeutics, INC. | $5,100.00 | 2020 | |
| Bioptics, INC. | $2,039.46 | 2019 | |
| Daiichi Sankyo INC. | $1,211.81 | 2025 | Enhertu |
| Leica Microsystems INC. | $951.51 | 2022-2025 | Mammotome Elite |
| Myriad Genetic Laboratories, INC. | $608.42 | 2021-2023 | Myrisk |
| Molli Surgical (US) INC | $582.74 | 2022-2024 | |
| Merit Medical Systems INC | $263.58 | 2021-2023 | Savi Scout |
| Impedimed, INC. | $162.60 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $61.54 | 2022 | |
| Stryker Corporation | $59.61 | 2019 | |
| Merck Sharp & Dohme LLC | $39.62 | 2023 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawna Willey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.